Lilly(Eli) & CoのNet debt/EBITDA
Lilly(Eli) & CoのNet debt/EBITDAは何ですか。
Lilly(Eli) & CoのNet debt/EBITDAは5.93です。
Net debt/EBITDAの定義は何ですか。
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
NYSEのセクタHealth CareにおけるNet debt/EBITDAの企業と比べるLilly(Eli) & Co
Lilly(Eli) & Coは何をしますか。
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Lilly(Eli) & Coと類似のnet debt/ebitda
- HUTCHMED (China)のNet debt/EBITDAは5.92です。
- Supply NetworkのNet debt/EBITDAは5.92です。
- Factset Research SystemsのNet debt/EBITDAは5.92です。
- Schaltbau AGのNet debt/EBITDAは5.92です。
- Anaplan IncのNet debt/EBITDAは5.92です。
- Lefroy ExplorationのNet debt/EBITDAは5.92です。
- Lilly(Eli) & CoのNet debt/EBITDAは5.93です。
- HP IncのNet debt/EBITDAは5.93です。
- Curtiss-WrightのNet debt/EBITDAは5.93です。
- Polymetal International PlcのNet debt/EBITDAは5.93です。
- Protalix BioTherapeuticsのNet debt/EBITDAは5.94です。
- International PaperのNet debt/EBITDAは5.94です。
- Oxford IndustriesのNet debt/EBITDAは5.94です。